MedPath

A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants

Phase 2
Completed
Conditions
Venous Thromboembolism
Interventions
Registration Number
NCT06454630
Lead Sponsor
Regeneron Pharmaceuticals
Brief Summary

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement (TKR) surgery.

The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related diseases after unilateral total knee replacement surgery.

The study is looking at several other research questions, including:

* What side effects may happen from taking the study drug

* How much study drug is in the blood at different times

* Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
179
Inclusion Criteria
  1. Undergoing a primary elective unilateral TKA
  2. Has a body weight โ‰ค130 kg at screening visit
  3. Is judged by the investigator to be in good health based on medical history, physical examination, vital sign measurements, and electrocardiograms (ECG's) performed at screening and/or prior to administration of initial dose of study drug as described in the protocol
  4. Is in good health based on laboratory safety testing obtained during the screening period as described in the protocol

Key

Exclusion Criteria
  1. History of bleeding in the past 6 months prior to dosing requiring hospitalization or transfusion; history of intracranial or intraocular bleeding, excessive operative or post-operative bleeding, and traumatic spinal or epidural anesthesia; history of bleeding diathesis
  2. History of thromboembolic disease or thrombophilia
  3. History of major surgery, including brain, spinal, or ocular, within approximately the past 6 months
  4. History of major trauma within approximately the past 6 months prior to dosing
  5. Hospitalized (>24 hours) for any reason within 30 days of the screening visit
  6. Has an estimated glomerular filtration rate (GFR) of <45 mL/min/1.73m^2 at the screening visit using one of the following formulas: the Modification of Diet in Renal Disease (MDRD) equation, the Chronic Kidney Disease Epidemiology Collaboration equation, or equivalent equation

Note: Other protocol-defined Inclusion/ Exclusion Criteria apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
REGN7508REGN7508-
EnoxaparinEnoxaparin-
Primary Outcome Measures
NameTimeMethod
Incidence of confirmed, adjudicated VTEThrough day 12
Secondary Outcome Measures
NameTimeMethod
Incidence of major bleedingUp to approximately Day 12
Incidence of clinically relevant non-major (CRNM) bleedingUp to approximately Day 12
Incidence of treatment emergent adverse events (TEAEs)Through end of study; approximately Day 75
Incidence of major VTEThrough day 12
Incidence of Deep venous thrombosis (DVT)Approximately Day 12
Concentrations of REGN7508 in serumThrough end of study; approximately Day 75
Change in activated partial thromboplastin time (aPTT)Baseline to end of study; approximately Day 75
Change in prothrombin time (PT)Baseline to end of study; approximately Day 75
Incidence of anti-drug antibodies (ADA) to REGN7508Through end of study; approximately Day 75
Titer of ADA to REGN7508Through end of study; approximately Day 75

Trial Locations

Locations (14)

Multi-profile Hospital for Active Treatment Hearth and Brain EAD

๐Ÿ‡ง๐Ÿ‡ฌ

Pleven, Bulgaria

Multiprofile Hospital For Active Treatment Park Hospital Ltd.

๐Ÿ‡ง๐Ÿ‡ฌ

Plovdiv, Bulgaria

Budai Irgalmasrendi Korhaz

๐Ÿ‡ญ๐Ÿ‡บ

Budapest, Hungary

Szolnoki MAV Hospital

๐Ÿ‡ญ๐Ÿ‡บ

Szolnok, Hungary

Vidzemes Hospital

๐Ÿ‡ฑ๐Ÿ‡ป

Valmiera, Valmieras Aprinkis, Latvia

Liepaja Regional Hospital

๐Ÿ‡ฑ๐Ÿ‡ป

Liepaja, Latvia

Riga's 2nd Hospital

๐Ÿ‡ฑ๐Ÿ‡ป

Riga, Latvia

Hospital of Traumatology and Orthopaedics

๐Ÿ‡ฑ๐Ÿ‡ป

Riga, Latvia

Orto Klinika

๐Ÿ‡ฑ๐Ÿ‡ป

Riga, Latvia

Lietuvos sveikatos mokslu universiteto ligonine Kauno klinik

๐Ÿ‡ฑ๐Ÿ‡น

Kaunas, Kauno Apskritis, Lithuania

Lithuanian University of Health Sciences Kaunas Hospital

๐Ÿ‡ฑ๐Ÿ‡น

Kaunas, Lithuania

Klaipeda University Hospital

๐Ÿ‡ฑ๐Ÿ‡น

Klaipeda, Lithuania

Specjalistyczny Szpital im. E. Szczeklika w Tarnowie

๐Ÿ‡ต๐Ÿ‡ฑ

Tarnow, Malopolskie, Poland

Clinic of Orthopaedics and Paediatric Orthopaedics

๐Ÿ‡ต๐Ÿ‡ฑ

Lodz, ลรณdzkie, Poland

ยฉ Copyright 2025. All Rights Reserved by MedPath